Century Therapeutics Inc
NASDAQ:IPSC
During the last 3 months Century Therapeutics Inc insiders bought 79.6k USD , and sold 1k USD worth of shares. The stock price has increased by 350% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/ipsc/vs/indx/gspc">open performance analysis).
The last transaction was made on
Feb 3, 2026
by
Carr Douglas
, who
sold
588.5 USD
worth of
IPSC shares.
During the last 3 months Century Therapeutics Inc insiders bought 79.6k USD , and sold 1k USD worth of shares. The stock price has increased by 350% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/ipsc/vs/indx/gspc">open performance analysis).
The last transaction was made on
Feb 3, 2026
by
Carr Douglas
, who
sold
588.5 USD
worth of
IPSC shares.
Century Therapeutics Inc
Glance View
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. The company is headquartered in Philadelphia, Pennsylvania and currently employs 170 full-time employees. The company went IPO on 2021-06-17. The firm is focused on developing transformative allogeneic, pluripotent stem cells (iPSC)-derived natural killer (NK) and T cell therapies to create products for the treatment of both solid tumor and hematological malignancies. Its Allo-Evasion technology is intended to prevent rejection of cell products by the host immune system, and manufacturing capabilities intended to minimize product development and supply risk. The firm's pipeline includes CNTY-101, CNTY-103, CNTY-102 and CNTY-104. The Company’s lead product candidate, CNTY-101, is focused on targeting B-cell lymphoma. CNTY-103 is designed to treat glioblastoma. CNTY-102 is designed to improve B-cell malignancy treatment. CNTY-104, is being developed to treat acute myeloid leukemia (AML). CAR design is a component of cell therapy product candidates. In addition to its programs, the Company is also actively engaged in a number of earlier stage discovery programs.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.